| OS | |||
---|---|---|---|---|
 | Univariate analysis | Multivariate analysis | ||
Variable | HR (95% CI) | p-value | HR (95% CI) | p-value |
Age ≥ 60 vs. <60 | 1.30 [0.93,1.81] | 0.121 | 0.82 [0.56,1.22] | 0.332 |
Female vs. Male | 0.90 [0.64,1.26] | 0.535 | Â | Â |
Smoking status Yes vs. Never | 1.24 [0.86,1.77] | 0.247 | Â | Â |
KPS ≤ 70 vs. ˃70 | 2.22 [1.41,3.52] | 0.001 | 1.56 [0.96,2.53] | 0.074 |
BMs at initial diagnosis Metachronous vs. Synchronous | 1.88 [1.31,2.71] | 0.001 | 2.18 [1.44,3.30] | < 0.001 |
BM Numbers ˃4 vs. 1–4 | 1.60 [1.14,2.24] | 0.007 | 1.35 [0.90,2.02] | 0.147 |
Symptoms of BMs Yes vs. No | 1.21 [0.86,1.68] | 0.273 | Â | Â |
ECM Yes vs. No | 1.94 [1.27,2.95] | 0.002 | 1.01 [0.59,1.74] | 0.974 |
EGFR mutation | Â | Â | Â | Â |
L858R vs. 19 del | 1.81[1.27,2.58] | 0.001 | 1.81 [1.23,2.65] | 0.002 |
Nonclassic vs. 19 del | 2.82[1.50,5.31] | 0.001 | 1.99 [1.01,3.91] | 0.047 |
Treatment of EGFR-TKIs at BMs | Â | Â | Â | Â |
3rd vs. 1/2rd EGFR-TKIs | 0.89 [0.63,1.26] | 0.504 | Â | Â |
Treatment Modality | Â | Â | Â | Â |
Upfront WBRT vs. Upfront TKI | 1.20[0.83,1.75] | 0.337 | 1.25 [0.84,1.86] | Â |
Upfront SRS/fSRS vs. Upfront TKI | 0.54[0.32,0.90] | 0.018 | 0.61 [0.36,1.03] | 0.066 |
DS-GPA 2.0–4.0 vs. 0-1.5 | 0.47 [0.33,0.66] | < 0.001 | 0.54 [0.33,0.90] | 0.017 |